Barro, Eduardo D.

HRN: 21-88-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/08/2022
09/15/2022
IV
4.5grams
Q6h
CVD Prob Bleed; T/C Aspiration Pneumonia; HCVD
Waiting Final Action 
09/16/2022
CEFIXIME 200MG (CAP)
09/16/2022
09/23/2022
PO
200mg
BID
URTI
Waiting Final Action 
09/24/2022
CEFTRIAXONE 1G (VIAL)
09/24/2022
09/30/2022
IV
2g
OD
Aspiration Pneumonia
Waiting Final Action 
09/24/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/24/2022
09/28/2022
PO
500mg
OD
Aspiration Pneumonia
Waiting Final Action 
09/30/2022
CEFIXIME 200MG (CAP)
09/30/2022
10/02/2022
PO
200mg
BID
Aspiration Pneumonia
Waiting Final Action 
10/02/2022
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
10/02/2022
10/09/2022
OPHTHALMIC
0.5%
TIDO
Bacterial Conjunctivitis
Waiting Final Action 
10/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/04/2022
10/11/2022
IV
4.5g
Q8
T/C HAP
10/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/04/2022
10/11/2022
IVTT
4.5g
Q6
T/C HAP
Waiting Final Action 
10/05/2022
CEFTAZIDIME 1GM (VIAL)
10/05/2022
10/15/2022
IV
1g
Q8
T/C HAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: